Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Cash Flow-to-Debt Ratio
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CN¥112.12 Million could theoretically repay 0% of its total liabilities (CN¥3.76 Billion) in one year. Explore 000623 long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Jilin Aodong Pharmaceutical Group Co Ltd across 28 annual periods. Also explore how large is Jilin Aodong Pharmaceutical Group Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Jilin Aodong Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see Jilin Aodong Pharmaceutical Group Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥272.26 Million | CN¥3.53 Billion | ▲ +382.2% |
| 2024 | 0.02x | CN¥59.48 Million | CN¥3.72 Billion | ▲ +12.0% |
| 2023 | 0.01x | CN¥68.06 Million | CN¥4.77 Billion | ▼ -83.7% |
| 2022 | 0.09x | CN¥423.86 Million | CN¥4.84 Billion | ▲ +8.5% |
| 2021 | 0.08x | CN¥324.85 Million | CN¥4.03 Billion | ▼ -19.9% |
| 2020 | 0.10x | CN¥390.41 Million | CN¥3.88 Billion | ▼ -10.9% |
| 2019 | 0.11x | CN¥379.46 Million | CN¥3.36 Billion | ▲ +11.0% |
| 2018 | 0.10x | CN¥347.64 Million | CN¥3.41 Billion | ▼ -47.7% |
| 2017 | 0.19x | CN¥256.49 Million | CN¥1.32 Billion | ▼ -14.5% |
| 2016 | 0.23x | CN¥333.81 Million | CN¥1.47 Billion | ▲ +32.0% |
| 2015 | 0.17x | CN¥388.03 Million | CN¥2.25 Billion | ▼ -33.7% |
| 2014 | 0.26x | CN¥288.83 Million | CN¥1.11 Billion | ▲ +30.0% |
| 2013 | 0.20x | CN¥201.22 Million | CN¥1.01 Billion | ▼ -11.3% |
| 2012 | 0.23x | CN¥272.40 Million | CN¥1.21 Billion | ▲ +105.3% |
| 2011 | 0.11x | CN¥108.30 Million | CN¥985.86 Million | ▼ -58.9% |
| 2010 | 0.27x | CN¥174.22 Million | CN¥652.43 Million | ▼ -24.6% |
| 2009 | 0.35x | CN¥213.03 Million | CN¥601.83 Million | ▼ -4.4% |
| 2008 | 0.37x | CN¥235.03 Million | CN¥634.74 Million | ▼ -28.3% |
| 2007 | 0.52x | CN¥384.69 Million | CN¥744.94 Million | ▲ +159.4% |
| 2006 | 0.20x | CN¥187.99 Million | CN¥944.28 Million | ▲ +21.3% |
| 2005 | 0.16x | CN¥136.26 Million | CN¥829.84 Million | ▼ -33.1% |
| 2004 | 0.25x | CN¥218.53 Million | CN¥890.13 Million | ▼ -0.2% |
| 2003 | 0.25x | CN¥147.65 Million | CN¥600.19 Million | ▲ +3379.2% |
| 2002 | -0.01x | CN¥-4.58 Million | CN¥609.94 Million | ▼ -102.8% |
| 2001 | 0.27x | CN¥138.76 Million | CN¥512.58 Million | ▲ +14.3% |
| 2000 | 0.24x | CN¥77.04 Million | CN¥325.23 Million | ▼ -0.1% |
| 1999 | 0.24x | CN¥110.18 Million | CN¥464.78 Million | ▲ +263.0% |
| 1998 | -0.15x | CN¥-30.90 Million | CN¥212.43 Million | — |